Veterinary Rehabilitation Services Market Value to touch US$ 2.1 Billion by 2033 | Says FMI Analyst

 The global Veterinary Rehabilitation Services Market size is valued at US$ 792.5 Million in 2022 and it is anticipated to achieve a market valuation of US$ 882 Million in 2023. It is expected to reach a market valuation of US$ 2.1 Billion by the end of the forecast period while exhibiting a CAGR of 9.06%.

To learn more about this report @ https://www.futuremarketinsights.com/reports/veterinary-rehabilitation-services-market

The rising number of companion animals & pet humanization trends, increasing prevalence of musculoskeletal & orthopedic disorders among animals, and growing awareness among pet owners regarding physical rehabilitation as non-invasive & drug-free treatment are some of the key factors driving this market. In addition, with the rising number of people valuing wildlife conservation, the count of volunteer rehabilitators who rescue and protect wounded/injured wildlife animals is also increasing. For instance, according to a study published in March 2022, by the National Library of Medicine, millions of native animals are rescued, rehabilitated, and protected by wildlife rehabilitators each year globally.

The COVID-19 pandemic adversely impacted the veterinary rehabilitation services market, especially during the year 2020. This negative impact was majorly due to the lockdowns in various countries which resulted in the closure and restricted access to veterinary care. This circumstance has created hurdles among pet owners in accessing veterinary rehabilitation services for their beloved companions due to the cancellation and mandatory closure of rehab centers. Moreover, wildlife rehabilitation centers have faced severe challenges during the pandemic with disease contamination risks within the facilities and among native habitats. This concern led the wildlife rehab centers to have interrupted veterinary visits or reduced personnel by around 85% in specific cases.

Furthermore, the increasing adoption of pet insurance with rehabilitation services coverage, post-pandemic return to normality with the resumption of veterinary rehab services, growth in the number of vet rehab centers, and increased pet healthcare expenditure are some of the other factors propelling the veterinary rehabilitation services market. According to the American Pet Products Association (APPA), the pet care expenditure in the U.S. raised to reach 123.6 billion in 2021 from USD 90.5 billion in 2018. Hence, the increasing annual pet healthcare expenditure is one of the major factors driving the market growth. Moreover, the rising popularity of veterinary rehab has reflected the devotion of pet owners who have proven their willingness to invest more time and money in their pets’ healthcare. Considering the perceived applications and benefits of rehab, the sector is expected to grow at a fast pace in veterinary medicine.

Key Takeaways-

  • The veterinary rehabilitation services market was valued at USD 510 million in 2019 and it will reach an impressive valuation of USD 2.1 billion while exhibiting a CAGR of 12.1% by 2033.
  • Pet humanization trends and increasing pet expenditure are augmenting the growth of the veterinary rehab service market.
  • By Animal type, the companion animal segment is expected to dominate the market with a 70% revenue share by 2033.
  • By therapy type, the therapeutic exercises segment is expected to generate the highest revenue during the forecast period.
  • By Indication type, Post surgery segment accounted for a market share of 31% in 2022 and is anticipated to lead the segment by the end of the forecast period.
  • By End-use, Veterinary rehab centers dominated the market with a 45.8 % segment share in 2022.
  • APAC will exhibit the highest CAGR of 13% in the veterinary rehab service market in the upcoming years.

“The market's expansion may be linked to a paradigm shift toward workflows and process automation across a wide range of businesses and industrial verticals. Enterprises all over the world are eager to embrace effective and smooth business processes that can be executed regardless of location, which is propelling this industry ahead.” comments a Future Market Insights analyst

Competitive Landscape-

Some of the major company profiles included in the global veterinary rehabilitation services market report are-

Back on Track Veterinary Rehabilitation Center LLC, Animal Acupuncture and Rehabilitation Center, BARC, Treasure Coast Animal Rehab & Fitness, Animal Rehab Center of Michigan, Blue Springs Animal Rehabilitation Center, Essex Animal Hospital, Triangle Veterinary Referral Hospital, Butterwick animal rehab clinic Ltd, Animal Rehab and Conditioning Center.

  • In April 2022, the FDA approved Vatinoxan hydrochlorides and Medetomidine injections for dogs undergoing specific clinical examinations and procedures and minor surgical operations. Medetomidine is a synthetic drug used as a surgical anesthetic and an analgesic. Vatinoxan brings down the adverse cardiovascular effects of medetomidine by maintaining the heart rate in the normal range, thus improving the cardiovascular function and the safety profile of medetomidine while the dog is sedated. Zenalpha is aimed to provide sedation and relief of pain that lasts for the duration of the sedation to dogs for clinical examinations or procedures which require the dog to remain still, calm or quiet.
  • In January 2022, the US FDA provided approval to Elanco Animal Health's Zorbium which is a (buprenorphine transdermal solution). Due to this approval, veterinarians now have another alternative for managing postoperative pain in cats, owing to this approval.

View Full Report @ https://www.futuremarketinsights.com/reports/veterinary-rehabilitation-services-market

 

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Primary Sclerosing Cholangitis (PSC) Market Size, Opportunities and Forecast 2023-2033

Image
  The global Primary Sclerosing Cholangitis (PSC) Market is anticipated to be worth US$ 151.07 million in 2023.  Primary Sclerosing Cholangitis (PSC) With growing alcohol consumption, the worldwide market for Primary Sclerosing Cholangitis (PSC) is expected to develop at a CAGR of 7.6% between 2023 and 2033, totaling roughly US$ 314.26 Million by 2033. According to the analysis of Future Market Insights, the Primary Sclerosing Cholangitis (PSC) market is expected to fuel over the analysis period, attributed to the factors such as the rise in the incidences of liver diseases, as well as rise in alcohol consumption. Get Full Access @ https://www.futuremarketinsights.com/reports/primary-sclerosing-cholangitis-psc-market  As per the Centers for Disease Control and Prevention, the global incidence of liver disease was 3.9 million in 2016. As per the World Health Organization (WHO), prevalence of liver cirrhosis is increasing in the European countries, due to high con...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more